“We have a lot of work to do now to help member cardiac care associates to be prepared for all the changes coming, and to find and collectively share new ways to gain efficiency and reduce costs without compromising quality of care.”
FREEPORT, The Bahamas, May 29, 2013 (PRWEB) May 30, 2013
FREEPORT, The Bahamas, May 29, 2013 – Okyanos Heart Institute, whose mission it is to bring a new standard of care and better quality of life to patients with chronic coronary artery disease using cardiac stem cell therapy, announces that Chief Medical Officer Howard Walpole Jr., M.D., MBA, FACC, FACAI recently spoke at The American College of Cardiology’s (ACC’s) Illinois state chapter’s 10th annual conference. The conference included an audience of cardiologists and cardiac care associates, including hospital and group administrators, and was held at the Hyatt Lodge in Oakbrook, Illinois, on May 18th from 7:30 a.m. to 4:00 p.m.
Dr. Walpole gave a talk about new demands on cardiology practice management in the midst of regulatory changes and healthcare reform. The changes with reform impact most aspects of healthcare service delivery: the cost of healthcare, insurance filing and reimbursements, documentation and coding changes and the need to gain efficiency and accuracy.
The Health Reform Law will result in substantive changes throughout the health care industry, including (1) expanded coverage for millions of uninsured Americans, (2) reduced Medicare program spending, (3) increased Medicaid enrollment and spending, and (4) substantive health insurance industry reform.
“One example of the changes is that the number of diagnostic codes will go from approximately 13,000 to 68,000 in October, 2014,” said Walpole. “We have a lot of work to do now to help member cardiac care associates to be prepared for all the changes coming, and to find and collectively share new ways to gain efficiency and reduce costs without compromising quality of care.”
More information about the chapter can be found at http://www.ilacc.org
ABOUT OKYANOS HEART INSTITUTE:
Based in Freeport, The Bahamas, Okyanos Heart Institute adheres to U.S. surgical center standards and is led by Chief Medical Officer Howard T. Walpole Jr., M.D., MBA, FACC, FACAI. The mission of Okyanos Heart Institute is to bring a new standard of care and a better quality of life to patients with chronic coronary artery disease using cardiac stem cell therapy. Okyanos Treatment utilizes cardiac stem cell therapy, a unique blend of stem and regenerative cells to support the growth of new blood vessels and to assist the heart in repairing tissue damaged by heart attack and disease. The Greek god of rivers, “Okyanos” symbolizes the primary mechanism of action that these adult stem cells have on ischemic (lack of blood flow) heart tissue, the result of the plaque deposits in the coronary arteries. The stem cells, derived from a person’s adipose (fat) tissue, create new blood vessels, a process known as angiogenesis. The treatment helps to facilitate blood flow in the heart and intake and use of oxygen, as measured by a rigorous clinical trial known as the PRECISE trial, as well as cardiac cell therapy trials at leading research institutions. For more information, log on to http://www.okyanos.com/.